Banque Cantonale Vaudoise Raises Stock Holdings in Cigna Group $CI

Banque Cantonale Vaudoise increased its position in Cigna Group (NYSE:CI) by 17.6% during the 4th quarter, Holdings Channel.com reports. The firm owned 17,267 shares of the health services provider’s stock after purchasing an additional 2,590 shares during the period. Banque Cantonale Vaudoise’s holdings in Cigna Group were worth $4,753,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. OLD National Bancorp IN boosted its holdings in Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after acquiring an additional 37 shares in the last quarter. Leavell Investment Management Inc. boosted its holdings in Cigna Group by 3.8% in the third quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider’s stock worth $318,000 after acquiring an additional 40 shares in the last quarter. Physician Wealth Advisors Inc. boosted its holdings in Cigna Group by 1.5% in the third quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock worth $782,000 after acquiring an additional 41 shares in the last quarter. Cookson Peirce & Co. Inc. boosted its holdings in Cigna Group by 0.8% in the third quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after acquiring an additional 41 shares in the last quarter. Finally, Signet Financial Management LLC boosted its holdings in Cigna Group by 0.6% in the third quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock worth $2,150,000 after acquiring an additional 41 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Up 1.6%

Cigna Group stock opened at $291.37 on Wednesday. The stock has a market cap of $77.08 billion, a PE ratio of 12.35, a price-to-earnings-growth ratio of 1.00 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The stock has a fifty day moving average of $275.45 and a 200 day moving average of $275.51.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, sell-side analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Insider Buying and Selling

In related news, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CI. Raymond James Financial set a $340.00 price target on Cigna Group in a report on Friday, May 1st. Barclays upped their price target on Cigna Group from $303.00 to $310.00 and gave the company an “overweight” rating in a report on Friday, May 1st. Truist Financial upped their price target on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. The Goldman Sachs Group upped their price target on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, Cantor Fitzgerald upped their price target on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $338.35.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.